Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|6|591-604

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.6, 2007-09, pp. : 591-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

By Fujino H.   Regan J.W.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 335-340

Elsevier

Access to resources Recommend Favorite

Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 4, 2017-02 ,pp. : 235-248

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3 Kinase Signaling Pathway in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 157-164

Bentham Science Publishers

Access to resources Recommend Favorite

Akt in Prostate Cancer: Possible Role in Androgen-Independence

By  

Current Drug Metabolism, Vol. 4, Iss. 6, 2003-12 ,pp. : 487-496

Bentham Science Publishers

Access to resources Recommend Favorite